Showing results (121-130 of 137) with videos related to

Sort By:
Pageof 14
Cardiology Journal|February 26, 2021
Sex-related impact on clinical outcomes of patients treated with drug-eluting stents according to clinical presentation: Patient-level pooled analysis from the GRAND-DES registryEun-Seok Shin, Eun Jung Jun, Jung-Kyu Han, et al.
Clinical Therapeutics|April 21, 2018
Efficacy and Safety of Fixed-dose Combination Therapy With Telmisartan and Rosuvastatin in Korean Patients With Hypertension and Dyslipidemia: TELSTA-YU (TELmisartan-rosuvaSTAtin from YUhan), a Multicenter, Randomized, 4-arm, Double-blind, Placebo-controlled, Phase III StudyGyu Chul Oh, Jung-Kyu Han, Ki Hoon Han, et al.
Korean Circulation Journal|October 17, 2017
Clinical and Angiographic Outcomes of the First Korean-made Sirolimus-Eluting Coronary Stent with Abluminal Bioresorbable PolymerHyoung Mo Yang, Kyoung Woo Seo, Junghan Yoon, et al.
Medicine|June 9, 2021
Five-year clinical outcomes of the first Korean-made sirolimus-eluting coronary stent with abluminal biodegradable polymerKyoung-Woo Seo, Hyoung-Mo Yang, Junghan Yoon, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 22, 2015
Usefulness of combined intravascular ultrasound parameters to predict functional significance of coronary artery stenosis and determinants of mismatchYun-Kyeong Cho, Chang-Wook Nam, Jung-Kyu Han, et al.
Korean Circulation Journal|June 3, 2022
Erratum: Correction of Text in the Article "Prasugrel-based De-Escalation of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With STEMI"You-Jeong Ki, Bong Ki Lee, Kyung Woo Park, et al.
Korean Circulation Journal|February 7, 2022
Prasugrel-based De-Escalation of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With STEMIYou-Jeong Ki, Bong Ki Lee, Kyung Woo Park, et al.
Lancet (London, England)|February 3, 2026
Dual antiplatelet therapy after percutaneous coronary intervention according to bleeding risk (HOST-BR): an open-label, multicentre, randomised clinical trialJeehoon Kang, Kyung Woo Park, Jung-Kyu Han, et al.
Trials|September 17, 2015
Harmonizing Optimal Strategy for Treatment of coronary artery diseases--comparison of REDUCtion of prasugrEl dose or POLYmer TECHnology in ACS patients (HOST-REDUCE-POLYTECH-ACS RCT): study protocol for a randomized controlled trialJoo Myung Lee, Ji-Hyun Jung, Kyung Woo Park, et al.
The American Journal of Cardiology|September 14, 2014
Three-year patient-related and stent-related outcomes of second-generation everolimus-eluting Xience V stents versus zotarolimus-eluting resolute stents in real-world practice (from the Multicenter Prospective EXCELLENT and RESOLUTE-Korea Registries)Joo Myung Lee, Kyung Woo Park, Jung-Kyu Han, et al.
Pageof 14